FTSE 100 rises on strong earnings; healthcare, industrials lead

By Reuters News

- Britain's FTSE 100 climbed on Thursday, led by gains in healthcare and industrials, as a slew of positive corporate earnings lifted sentiment and investors digested the latest economic growth data.

The blue-chip FTSE 100 index .FTSE rose 0.34% to 10,872.62 points by 1131 GMT, while the midcap FTSE 250 .FTMC climbed 0.25%.

  • The aerospace and defence sector .FTNMX502010 gained 1.4% with Rolls-Royce RR.L up 2.8% after reaffirming its full-year forecast and announcing a £1.5 billion share buyback

  • Healthcare heavyweights AstraZeneca AZN.L and GSK GSK.L climbed 0.9% and 1.1%, respectively

  • Burberry BRBY.L jumped 9.4% after the luxury brand reported second-quarter sales and profit above estimates

  • Persimmon PSN.L gained 6.2% after the homebuilder forecast a further increase in housing volumes in 2027; broader homebuilder sector .FTNMX402020 climbed 3.9%

  • B&M BMEB.L jumped 18.3% after the discount retailer said its annual profit may rise by up to 16%; stock was the biggest gainer among UK midcaps

  • Offsetting some gains, energy giants Shell SHEL.L and BP BP.L inched 0.6% lower each, tracking lower crude oil prices

  • Endeavour Mining EDV.L slumped 6.3% after the gold miner said it sees full-year gold production at the lower end of its outlook

  • Industrial metal miners .FTNMX551020 dipped 0.6%, tracking lower base metal prices, including copper

  • Britain's economy grew 0.7% in the third quarter, its fastest pace in 2-1/2 years, supported by strong services activity and AI-related demand

  • The latest Royal Institution of Chartered Surveyors survey showed its house price balance fell to -36 in October from -34 in September, while agreed sales weakened to -24 from -18 and its sales outlook for the next 12 months dropped to -17

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.